Haematological Malignancies 2 —
Training activity: 12

Details

Assist with the preparation of SIHMDS integrated reports for haematological malignancies

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What do you know about the requirements for integrated reporting with other specialties for SIHMDS compliance?
• What information needs to be included in a SIHMDS integrated report for haematological malignancies? Which specialties need to contribute to these reports? What are the relevant guidelines and protocols for preparing these reports? What aspects of the investigations of haematological malignancies need to be summarised?
• How can you ensure that the genomic findings are accurately and effectively communicated within the integrated report? What are the challenges in achieving SIHMDS compliance?
• Review examples of SIHMDS integrated reports for haematological malignancies. Consider potential challenges in data collation and interpretation across different specialties.
• Reflect on your current understanding of integrated reporting requirements.
• Discuss with the relevant personnel the specific reports you will be assisting with and the data sources involved.

In action

• What are your current tasks in preparing the report (e.g., collating information from different sources, summarising key findings, ensuring consistency across sections). Why are you approaching these tasks in this order?
• What decisions are you making regarding what information to include and how to present it in the integrated report?
• What aspects of data collation and integration feel more straightforward, and what requires more careful attention to detail and adherence to SIHMDS guidelines?
• How effectively are you gathering and synthesising information from various sources (e.g., laboratory systems, other specialty reports)?
• What challenges are you encountering in ensuring accuracy, completeness, and consistency of the integrated report?
• What are you learning about the specific requirements and format of SIHMDS integrated reports as you work on this task?
• Are there alternative ways to structure or present the information in the report to enhance clarity and integration?
• What support or clarification might you need from colleagues or supervisors regarding specific data points or reporting requirements?
• Are you ensuring that the report adheres to the relevant SIHMDS compliance standards?

On action

• What were the key components and information sources required for the SIHMDS integrated reports you assisted with? What were the challenges or straightforward aspects of gathering and synthesising the necessary information? What were the different specialty inputs that needed to be integrated into the reports?
• How has your understanding of the requirements for SIHMDS compliance and integrated reporting in haematological malignancies developed? What did you learn about the types of information and data that need to be included from different specialties? How did this experience enhance your understanding of the importance of data sharing and collaboration for comprehensive patient care? What did you learn about the practical steps involved in preparing these integrated reports?
• What specific aspects of SIHMDS integrated reporting do you need to understand better? How will you apply your learning to future tasks involving integrated reporting? What actions will you take to improve your understanding of the guidelines and best practices for SIHMDS reports? What resources or guidance would be helpful for further developing your skills in this area?

Beyond action

• Have you assisted with the preparation of further SIHMDS reports since this DTA? Have you noticed any patterns or recurring challenges in the process?
• Have you had opportunities to review completed SIHMDS reports and understand how the different specialty inputs are integrated?
• Looking back at your ‘reflect-on-action’ notes, have there been any updates or changes to SIHMDS guidelines or reporting requirements that you are now aware of?
• How has your understanding of the data and information required for SIHMDS compliance influenced your approach to collecting and documenting laboratory findings?
• How has this activity contributed to your awareness of the importance of integrated diagnostics in patient care?
• How will you continue to develop your understanding of integrated reporting and its role in the broader healthcare landscape?

Relevant learning outcomes

#	Outcome
# 3	Outcome Evaluate the urgency of testing for particular haematological malignancies to inform management decisions.
# 4	Outcome Analyse, interpret and prepare interpretive reports for common haematological malignancies, including results for somatic variants, clonality, and somatic hypermutation.
# 5	Outcome Interpret the associated IQC and EQA of the laboratory tests for investigation of haematological malignancies.
# 6	Outcome Practice with the relevant specialties for the diagnosis, monitoring and management of haematological malignancies.
# 7	Outcome Summarise the information and findings of investigations of haematological malignancies for integrated reporting in compliance with the requirements of an integrated diagnostic service.